106375-28-4CC(O)C1NC(=O)C(Cc2ccc(O)cc2)NC(=O)C2CC(O)CN2C(=O)C(CC(N)=O)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)C(CO)NC(=O)CNC(=O)C4CC(O)CN4C(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(N)CSSCC(NC(=O)C(CSSCC(C(=O)NC(Cc4ccc(O)cc4)C(N)=O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC1=O)NC(=O)C(CC(N)=O)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CC(O)CN1C(=O)C(CO)NC3=O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)N2FDQZTPPHJRQRQQ-UHFFFAOYSA-NSicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P260, P261, P262, P264, P270, P271, P280, P284, P301+P316, P302+P352, P304+P340, P316, P320, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Verwendenω-Conotoxin GVIA has been used as an antagonist for N-type calcium channel (CaV2.2) in various studies.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
106375-28-4